---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-076144"
form_type: "8-K"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2024-09-05T23:59:59+00:00"
generated_at: "2026-05-31T06:19:03.765046+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Cadrenal Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq letter on Sept 5 confirming closing bid price >=$1 for 10 consecutive business days (Aug 20-Sept 4).
- Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and the matter is closed.
- No further action required; stock continues trading on Nasdaq Capital Market under CVKD.

## SEC filing metadata
- accession: 0001213900-24-076144
- form_type: 8-K
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2024-09-05T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390024076144/0001213900-24-076144-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390024076144/ea021370601-8k_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-076144
- JSON: https://secwatch.observer/filing/0001213900-24-076144.json
- Plain text: https://secwatch.observer/filing/0001213900-24-076144.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.